S-1/A: IR-Med Inc. Files Amendment No. 2 to Form S-1 Registration Statement
S-1/A Filing
IR-Med, Inc. has filed an amendment to its S-1 registration statement, primarily to update exhibit information related to its proposed sale of common stock.
Summary
- IR-Med, Inc. filed Amendment No. 2 to its Registration Statement on Form S-1.
- The amendment primarily updates Item 16 of Part II, concerning exhibits.
- The company is registering for the sale of up to 80,000,000 shares of common stock.
- The shares will be sold from time to time pursuant to an Equity Purchase Agreement with Williamsburg Venture Holdings, LLC, dated March 11, 2025.
- The legal opinion from Sullivan & Worcester LLP confirms that the shares have been duly authorized and, when issued, delivered, and paid for, will be validly issued, fully paid, and non-assessable.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it primarily involves procedural filings for a potential offering. The legal opinion provides some reassurance, but the overall impact depends on market conditions and investor interest.
Positives
- Legal counsel has confirmed that the shares, when issued and paid for, will be validly issued, fully paid, and non-assessable.
Future Outlook
The company intends to sell shares of common stock from time to time.
Industry Context
This filing is a standard step for companies seeking to raise capital through public markets, particularly in the medical device sector.
Stakeholder Impact
- Shareholders may experience dilution depending on the pricing and extent of the offering.
- The capital raise could provide the company with additional resources for operations and growth.
Next Steps
- The registration statement needs to become effective.
- The company will then proceed with the sale of common stock as outlined in the Purchase Agreement.
Key Dates
| Date | Description |
|---|---|
| December 24, 2021 | Date of Stock Exchange Agreement among IR-Med, Inc., IR. Med Ltd. and the former stockholders of IR. Med Ltd. |
| June 6, 2024 | Date of Certificate of Amendment filed with the Secretary of State for the State of Nevada |
| July 7, 2024 | Date of Amended and Restated Consulting Agreement between IR. Med Ltd. and Aharon Klein and Yaniv Cohen |
| August 22, 2024 | Date of Employment agreement between IR.Med Ltd. and Ran Ziskind |
| March 1, 2024 | Date of Amendment and Extension to 2015 Loan Agreement between the Company and Aharon Klein and Yaniv Cohan |
| March 1, 2024 | Date of Amendment and Extension to 2017 Loan Agreement between the Company and Yaniv Cohan |
| March 1, 2024 | Date of Amendment and Extension to Convertible Bridge Loan between the Company and certain investors |
| March 11, 2025 | Date of Equity Purchase Agreement between IR-Med, Inc. and Williamsburg Venture Holdings, LLC |
| March 11, 2025 | Date of Registration Rights Agreement between IR-Med, Inc. and Williamsburg Venture Holdings, LLC |
| March 26, 2025 | Date of Note Purchase Agreement between the Company and certain shareholders |
| March 26, 2025 | Date of Convertible Loan Agreement between the Company and certain shareholders |
| May 22, 2025 | Date of the Registration Statement |
Keywords
S-1/A, Registration Statement, Common Stock, IR-Med, Securities, Offering, Equity Purchase Agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.